This press release was issued on the position statement released by ACMT regarding Florida’s SB 718 legislation that categorizes the reckless exposure of first responders to fentanyl as a second-degree felony.

The American College of Medical Toxicology (ACMT) has issued a position statement in response to the recent paper by Shearston et al reporting their study found trace concentrations of metals and metalloids in tampons.

The American College of Medical Toxicology (ACMT) has released a position statement, “Mifepristone and Misoprostol are Not Controlled Dangerous Substances,” in advance of the Louisiana law labeling them as such going into effect on October 1st.

ACMT was recently awarded a five-year, $1 million cooperative agreement with the Centers for Disease Control (CDC) to implement the “Strengthening the Public Health System and Services through a Capacity Building Assistance Program for Medical Toxicologists.”

ACMT’s ToxIC Fentanyl Analog Study has detected the veterinary medication, medetomidine in patients seen in the ED after suspected opioid overdose. Data from this study contributed to findings presented in a recent Morbidity and Mortality Weekly Report (MMWR) released by the CDC.

ACMT is pleased to announce the 2024 ACMT Annual Scientific Meeting (ASM) and Symposia taking place April 10 – 14 at the Omni Shoreham Hotel in Washington, DC.

Under a U.S. Food and Drug Administration (FDA) contract with the American College of Medical Toxicology (ACMT), the Toxicology Investigators Consortium (ToxIC) is expanding its Drug Overdose Toxico-Surveillance (DOTS) Reporting Program evaluating patients with opioid and stimulant overdoses.

“The 2023 Virtual Seminar in Forensic Toxicology: Expanding Worlds of Cannabinoids & Polydrug Exposures” is a two-day virtual seminar featuring distinguished industry experts addressing some of the most crucial topics affecting the medical and public health landscape today. Topics covered include cannabis and alternative cannabinoid impairment, and new research on medical legal death investigations involving polydrug exposures such as fentanyl, xylazine, benzodiazepines.

Under a U.S. Food and Drug Administration (FDA) contract awarded to the American College of Medical Toxicology’s (ACMT), the Toxicology Investigators Consortium (ToxIC) will examine the real-world administration of naloxone by community members, fire and police departments, and emergency medical services (EMS) personnel.

The CDC has collaborated with ACMT’s ToxIC, a multicenter research network led by physicians specializing in medical toxicology, to develop a comprehensive toxico-surveillance dashboard capturing real-time data on nonfatal overdoses involving fentanyl.

American College of Medical Toxicology (ACMT) symposium will address the ethics, psychology, management, and global epidemiology of the suicidal patient through a toxicology lens. 

Important study findings recently published in the Journal of Medical Toxicology (JMT) dovetail with the new change in the Data 2000 (“X”) Waiver process for prescribing buprenorphine. Findings demonstrate that a brief education session led clinicians to an increase in the recognition of opioid withdrawal and initiation of buprenorphine treatment for patients in the emergency department.

This one-day symposium draws on the expertise of professionals from multiple medical and social science fields to address drug/medication-related issues and psychosocial issues faced by pregnant women who have substance use disorders. This event, which will take place on Thursday, March 10, kicks off 4 days of programming as part of the American College of Medical Toxicology (ACMT) 2022 Annual Scientific Meeting. 

The American College of Medical Toxicology (ACMT) 2022 Annual Scientific Meeting (ASM) will be held virtually from Friday, March 11 through Sunday, March 13th. This event will be preceded by ACMT’s 1-Day Virtual Symposium “Drug Science Meets Social Science: Substance Use, Pregnancy, and Baby” on Thursday, March 10.

The American College of Medical Toxicology (ACMT) Toxicology Investigators Consortium (ToxIC) Fentanyl Analog Study has detected an outbreak of illicit benzodiazepine co-exposures in patients seen in the emergency department.

The American College of Medical Toxicology’s Toxicology Investigators Consortium (ToxIC) has received several reports of patients who became ill from using ivermectin formulations to prevent or treat COVID-19 infection. These incidents were reported through ToxIC’s FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project Sub-registry between October 2020 and August 2021.

March 2021 marks the one-year anniversary of the World Health Organization’s official designation of the outbreak of the COVID-19 pandemic. The response of the American College of Medical Toxicology (ACMT) to the pandemic has been immediate, urgent, and continuous. In March 2020, ACMT formed a task force of ACMT/medical toxicology professionals to lead its COVID-19 response and provide technical expertise.

Registration is open for ACMT’s virtual 2021 Annual Scientific Meeting, April 14-16.

The American College of Medical Toxicology (ACMT) will offer a one-day virtual symposium entitled “The 4th Wave: Methamphetamines and Stimulants” on Wednesday, April 13, 2020. The symposium will feature cutting-edge research examining current trends of methamphetamine and stimulant use and will appeal to healthcare providers and researchers involved with the care of patients with substance use disorders.

The American College of Medical Toxicology (ACMT) will present the 2021 Virtual ‘Total Tox  Course’ on three Fridays in February – the 5th, 12th, and 19th. Attendees may choose to register  for one, two, or for the complete course, all three days. The course is intended for a wide array  of healthcare professionals, including physicians, nurses, pharmacists, paramedics, EMTs, first  responders, and others.  

Dr. Satish Pillai, a Senior Liaison to Operation Warp Speed, will be the featured speaker for a January 6th, 2021 webinar offered by the American College of Medical Toxicology (ACMT.) Dr. Pillai will give an update on the current status of distribution and implementation strategies for COVID-19 vaccinations.

The COVID-19 Sub-Registry will be developed as an enhanced data collection tool within the ToxIC network that will specifically focus on identifying potential adverse reactions related to COVID-19 drug treatments. Physicians specialized in medical toxicology will oversee the program at 15 designated medical centers across various geographic regions in the United States.

Dr. Sara H. Goza, President of the American Academy of Pediatrics will be the featured speaker  for a November 4th webinar offered by the American College of Medical Toxicology (ACMT.)  Dr. Goza will address the topic of rising rates of COVID-19 infections among children and teens and recommend ways to keep families and communities safe as in-person classes resume. 

As physicians with expertise in pharmacology, adverse drug effects, and public health we are familiar with the many benefits and rare risks of vaccination. A COVID-19  vaccine, when and if available, promises to become a key part of our multifaceted approach to address the current public health crisis.

With great interest and concern, we have followed media reports of ketamine being administered by paramedics for sedating individuals at the direction of law enforcement officers to facilitate taking them into custody. 

The American College of Medical Toxicology (ACMT), the American Academy of Clinical Toxicology (AACT), and  the American Association of Poison Control Centers has issued the following joint statement in response to recent  discussions proposing use of oleandrin as a potential treatment for COVID-19.

As pressure mounts for schools to reopen this fall, awareness is growing of the need for specific plans on how schools will protect the health of children and their families, teachers, administrators, and school staff. The American College of Medical Toxicology’s COVID-19 webinar series has invited Healthy Schools Network Founder and Executive Director, Claire Barnett to provide expert guidance on this important topic on Wednesday, July 29 at 3:00 pm ET.

American College of Medical Toxicology offers free webinar “Medical Experts Explain the Use and Potential Adverse Effects of Chloroquine & Hydroxychloroquine for COVID-19”

Registration is open for two exciting ACMT events in March 2020 at the Grand Hyatt in New York City. 

The American College of Medical Toxicology has been awarded $500,000 from the Substance  Abuse and Mental Health Services Administration (SAMHSA) to develop high quality,  comprehensive curriculum on identification and treatment of SUDs. 

ACMT will present the 2019 ‘Total Tox Course’ on Monday, December 9 – Wednesday, December 11, 2019, in Washington, DC. The Total Tox Course is a comprehensive review of the scope of emergency toxicology and will include up-to-date interventions and management options for poisoned patients. Prominent experts in medical toxicology and emergency medicine will lead the course. 

ACMT presents the 2019 ‘Seminar in Forensic Toxicology: Criminal Poisoning & Drug Facilitated Sexual Assault: Forensic, Legal, and Medical Aspects’ on Monday, December 9 – Tuesday, December 10, 2019, in Washington, DC. 

The American College of Medical Toxicology recently published a Position Statement that strongly recommends removing the waiver (‘X-waiver’) requirement for prescribing buprenorphine for opioid use disorder (OUD). ACMT’s position has been endorsed by the American Academy of Clinical Toxicology, the American Academy of Emergency Medicine, and the American College of Emergency Physicians.

The American College of Medical Toxicology (ACMT) recently concluded its 16th Annual Scientific Meeting in San Francisco (April 11-14), where 162 research abstracts and more than 25 expert lectures on human poisoning were presented to an international group of more than 300 attendees from various medical specialties. Several ACMT members also received awards for research and service to ACMT and the field of Medical Toxicology.  

The American College of Medical Toxicology (ACMT) just concluded its 16th Annual Scientific Meeting in San Francisco (April 11-14), where 162 research abstracts and more than 25 expert lectures on human poisoning were presented to an international group of more than 300 attendees from various medical specialties.  

With generous support from the Independence Blue Cross Foundation under the Supporting Treatment and Overdose Prevention (STOP) program, the Medical Toxicology Foundation presents ‘Curbing the Opioid Crisis in Philadelphia: Increasing Emergency Department Initiation of Buprenorphine-Naloxone for Opioid Use Disorder’ in part as a response to spiking overdose deaths in Philadelphia.

“Microplastics and Human Health: Our Great Future to Think About Now” by Amy V. Kontrick, MD, published in the Journal of Medical Toxicology (April 2018), is among the top 10 downloaded articles in 2018 from all Springer Nature journals in the Pharmacology & Toxicology category.

Researchers from the American College of Medical Toxicology’s (ACMT’s) Toxicology Investigators Consortium (ToxIC), publish a study on poisoning with malicious or criminal intent with data collected from ToxIC’s case registry. 

Registration is open for ACMT’s ‘Legal Cannabis: Medical, Toxicological and Public Health Implications,’ a full day symposium on Thursday, April 11, 2019 at the  Westin St. Francis in San Francisco, CA.  

Registration is open for ACMT’s ‘New Frontiers in Medical Toxicology: Pharmacogenomics and Precision Medicine,’ a full day symposium on Thursday, April 11, 2019 at the Westin St. Francis in San Francisco, CA.

Join the American College of Medical Toxicology (ACMT) at the 2018 Seminar in Forensic Toxicology ‘Opioids, Toxicology, and the Law: Medical-Legal Aspects of the Opioid Epidemic’ on Thursday, December 13, and Friday, December 14, 2018, in Dallas, TX. 

A new video offers precautions and key messages for first responders who may come in contact with Fentanyl.

Join us in Chicago for ACMT’s ‘Total Tox Course’ for emergency providers on September 5— September 7. Register by July 25 to get the early-bird discount!

An outbreak of major bleeding complications associated with synthetic cannabinoid use may be caused by brodifacoum and other related contaminants

ACMT’s 2018 Annual Scientific Meeting (ASM) will be held Friday, April 6—Sunday, April 8, at the  Washington Marriott Georgetown in Washington DC. Our annual Satellite Session, ‘Toxic  Threats, Chemical Security, and Counterfeit Pharmaceuticals’ will precede ASM on Thursday,  April 5, at the same venue. 

ACMT offers new comprehensive toxicological training for providers who see poisoned patients. ACMT’s Total Tox Course will be held at the Wyndham Grand Chicago Riverfront on Wednesday,  September 5—Friday, September 7, 2018. 

ACMT’s 2018 Satellite Session, ‘Toxic Threats, Chemical Security and Counterfeit  Pharmaceuticals’ will be held on Thursday, April 5, at the Washington Marriott Georgetown in  Washington DC. 

The Centers for Medicare & Medicaid Services (CMS)  announced in late-December that they have approved six quality measures that were developed by the American College of Medical Toxicology (ACMT). These are the first-ever medical toxicology quality measures approved by CMS.

A position statement regarding fentanyl exposure in first responders, published by the American College of Medical Toxicology (ACMT) and American Academy of  Clinical Toxicology (AACT) in July 2017, continues to pave the way in clarifying risks of dermal and inhalation fentanyl exposure. 

Join the American College of Medical Toxicology (ACMT) and the Fredric  Rieders Family Foundation at the 2017 Seminar in Forensic Toxicology ‘Opioids, Toxicology,  and the Law: Medical-Legal Aspects of the Opioid Epidemic’ on Monday, December 11 and  Tuesday, December 12, 2017, at the Chemical Heritage Foundation in Philadelphia, PA. 

This unique conference will benefit health care professionals, scientists, social workers, attorneys, and law enforcement.

Fentanyl exposure safety precautions based on the experience of physicians who specialize in medical toxicology.

Synthetic cannabinoids (SCs), which are sold under hundreds of brand names including “spice” or “K2”, have become common drugs of abuse in the US. These man-made drugs are associated with severe central nervous system and cardiovascular effects.

A new, free, web resource is available for clinicians and families that will aid in the protection of children from exposures to health hazards in the environment. Access the peer-reviewed PEHT during well child visits to educate parents on everyday hazards related to air, water, food and products.

The American College of Medical Toxicology will hold its Annual Scientific Meeting in San Juan, Puerto Rico from March 31 – April 2, 2017. The conference will feature current research in the field of medical toxicology and will be accompanied by special satellite sessions on the opioid and Zika epidemics.

The American College of Medical Toxicology (ACMT) has received approval from The Center for Medicare and Medicaid (CMS) for a unique specialty code for medical toxicology.